Insider trading

Period: 120 months Stock: ROIV + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

227 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

227 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

227 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

227 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
227 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
227 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

227 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
1 Oct 2026
Sold on a plan 2×
$640.86K 17,750 at 36.10
54.3%
Sold half or more
30 Sep 2026
Venker Eric President & Immunovant CEO
Sold on a plan
$7.32M 200,000 at 36.62
11.1%
Planned (10b5-1)
15 Sep 2026
Sold on a plan 2×
$203.15K 5,112 at 39.74
12.4%
Planned (10b5-1)
15 Sep 2026
Sold on a plan 2×
$196.23K 4,938 at 39.74
33.3%
Planned (10b5-1)
8 Sep 2026
Sold on a plan
$798.00K 20,000 at 39.90
31.8%
Planned (10b5-1)
28 Aug 2026
Venker Eric President & Immunovant CEO
Sold on a plan 2×
$7.15M 200,000 at 35.77
11.1%
Planned (10b5-1)
21 Aug 2026
Sukhatme Mayukh President & CIO
Sold at will
$5.28M 144,756 at 36.48
0.8%
Not planned
20 Aug 2026
Sukhatme Mayukh President & CIO
Sold at will
$653.46K 17,519 at 37.30
0.1%
Not planned
19 Aug 2026
Sukhatme Mayukh President & CIO
Sold at will
$6.43M 172,899 at 37.17
0.9%
Not planned
18 Aug 2026
Sukhatme Mayukh President & CIO
Sold at will 2×
$5.03M 136,942 at 36.73
0.7%
Not planned
17 Aug 2026
Sukhatme Mayukh President & CIO
Sold at will
$10.32M 284,707 at 36.25
1.5%
Not planned
14 Aug 2026
Sukhatme Mayukh President & CIO
Sold at will
$8.81M 243,177 at 36.23
1.3%
Not planned
27 Jul 2026
Venker Eric President & Immunovant CEO
Sold on a plan
$6.99M 200,000 at 34.95
11.0%
Planned (10b5-1)
30 Jun 2026
Sold at will
$7.09M 200,000 at 35.45
10.3%
Not planned
30 Jun 2026
Gold Daniel Allen Director · indirect
Sold at will
$436.77K 12,380 at 35.28
0.1%
Not planned
30 Jun 2026
QVT Financial LP Director by Deputization · indirect
Sold at will
$436.77K 12,380 at 35.28
0.1%
Not planned
30 Jun 2026
MANCHESTER KEITH S Director · indirect
Sold at will
$436.77K 12,380 at 35.28
0.1%
Not planned
30 Jun 2026
Sold on a plan
$349.00K 10,000 at 34.90
18.9%
Planned (10b5-1)
29 Jun 2026
Gold Daniel Allen Director · indirect
Sold at will 2×
$27.64M 800,000 at 34.55
5.5%
Not planned
29 Jun 2026
QVT Financial LP Director by Deputization · indirect
Sold at will 2×
$27.64M 800,000 at 34.55
5.5%
Not planned
29 Jun 2026
MANCHESTER KEITH S Director · indirect
Sold at will 2×
$27.64M 800,000 at 34.55
5.5%
Not planned
29 Jun 2026
Sold on a plan 2×
$610.25K 17,750 at 34.38
51.9%
Sold half or more
26 Jun 2026
QVT Financial LP Director by Deputization · indirect
Sold at will 2×
$21.28M 625,783 at 34.00
4.1%
Not planned
26 Jun 2026
Gold Daniel Allen Director · indirect
Sold at will 2×
$21.28M 625,783 at 34.00
4.1%
Not planned
26 Jun 2026
MANCHESTER KEITH S Director · indirect
Sold at will 2×
$21.28M 625,783 at 34.00
4.1%
Not planned
26 Jun 2026
Sukhatme Mayukh President & CIO
Sold at will
$17.04M 500,000 at 34.08
2.6%
Not planned
25 Jun 2026
Sukhatme Mayukh President & CIO
Sold at will
$17.07M 500,000 at 34.13
2.6%
Not planned
24 Jun 2026
Venker Eric President & Immunovant CEO
Sold on a plan 2×
$6.63M 200,000 at 33.16
11.0%
Planned (10b5-1)
22 May 2026
Venker Eric President & Immunovant CEO
Sold on a plan
$6.05M 200,000 at 30.27
11.0%
Planned (10b5-1)
20 Apr 2026
Venker Eric President & Immunovant CEO
Sold on a plan
$5.92M 200,000 at 29.59
10.8%
Planned (10b5-1)
16 Apr 2026
Sold at will
$8.45M 289,774 at 29.16
1.7%
Not planned
8 Apr 2026
Humes Jennifer Chief Accounting Officer
Sold at will
$384.07K 13,538 at 28.37
13.9%
Not planned
26 Mar 2026
Sold at will
$1.92M 70,000 at 27.45
62.0%
Sold half or more
17 Mar 2026
Venker Eric President & Immunovant CEO
Sold on a plan
$5.65M 200,000 at 28.24
10.8%
Planned (10b5-1)
16 Mar 2026
Sold at will
$1.20M 41,861 at 28.68
72.6%
Sold half or more
23 Feb 2026
Torti Frank President and Vant Chair
Sold on a plan
$16.16M 587,390 at 27.51
4.1%
Planned (10b5-1)
20 Feb 2026
Torti Frank President and Vant Chair
Sold on a plan
$27.49M 1,012,610 at 27.15
6.9%
Planned (10b5-1)
19 Feb 2026
Torti Frank President and Vant Chair
Sold on a plan
$38.39M 1,400,000 at 27.42
9.2%
Planned (10b5-1)
13 Feb 2026
Gold Daniel Allen Director · indirect
Sold at will 2×
$9.96M 375,784 at 26.50
2.4%
Not planned
13 Feb 2026
QVT Financial LP Director by Deputization · indirect
Sold at will 2×
$9.96M 375,784 at 26.50
2.4%
Not planned
13 Feb 2026
MANCHESTER KEITH S Director · indirect
Sold at will 2×
$9.96M 375,784 at 26.50
2.4%
Not planned
13 Feb 2026
Venker Eric President & Immunovant CEO
Sold on a plan
$5.30M 200,000 at 26.49
10.8%
Planned (10b5-1)
12 Feb 2026
QVT Financial LP Director by Deputization · indirect
Sold at will 2×
$11.37M 425,000 at 26.75
2.7%
Not planned
12 Feb 2026
Gold Daniel Allen Director · indirect
Sold at will 2×
$11.37M 425,000 at 26.75
2.7%
Not planned
12 Feb 2026
MANCHESTER KEITH S Director · indirect
Sold at will 2×
$11.37M 425,000 at 26.75
2.7%
Not planned
11 Feb 2026
Gold Daniel Allen Director · indirect
Sold at will
$11.33M 425,000 at 26.67
2.6%
Not planned
11 Feb 2026
QVT Financial LP Director by Deputization · indirect
Sold at will
$11.33M 425,000 at 26.67
2.6%
Not planned
11 Feb 2026
MANCHESTER KEITH S Director · indirect
Sold at will
$11.33M 425,000 at 26.67
2.6%
Not planned
9 Feb 2026
Sukhatme Mayukh President & CIO
Sold at will
$8.99M 339,441 at 26.47
1.7%
Not planned
12 Jan 2026
Venker Eric President & Immunovant CEO
Sold on a plan
$4.38M 200,000 at 21.92
10.8%
Planned (10b5-1)
Showing 1–50 of 227. Page 1 of 5 Older →